Abstract
Abstract:Mild hypokalemia is common and encountered in a multitude of diseases, but severe hypokalemia leading to rhabdomyolysis is relatively rare. The watery diarrhea, hypokalemia, achlorhydria (WDHA) syndrome caused by vasoactive intestinal polypeptide (VIP)-producing tumors, is an extremely rare cause of hypokalemic rhabdomyolysis and the literature is limited to one case report. We report a second case of an adult who presented with rhabdomyolysis due to severe hypokalemia. Further evaluation revealed that he had a VIP-producing pancreatic neuroendocrine tumor (NET), which was the cause of his hypokalemic rhabdomyolysis. Although rare in occurrence, a high index of suspicion is of paramount importance for establishing the correct diagnosis and treatment.
This content is limited to qualifying members.
If you have an existing account please login now to access this article or view purchase options.
Create a free account, then purchase this article to download or access it online for 24 hours.
Create a free account, then purchase a subscription to get complete access to all articles for a full year.
References
References1. Huerta-Alardín AL, Varon J, Marik PE. Bench-to-bedside review: rhabdomyolysis—an overview for clinicians. Crit Care 2005;9:158–169.Huerta-AlardínAL]]VaronJ]]MarikPEBench-to-bedside review: rhabdomyolysis—an overview for clinicians.Crit Care20059158-1692. Onozawa M, Fukuhara T, Minoguchi M, et al. Hypokalemic rhabdomyolysis due to WDHA syndrome caused by VIP-producing composite pheochromocytoma: a case in neurofibromatosis type 1. Jpn J Clin Oncol 2005;35:559–563.OnozawaM]]FukuharaT]]MinoguchiM&etal;Hypokalemic rhabdomyolysis due to WDHA syndrome caused by VIP-producing composite pheochromocytoma: a case in neurofibromatosis type 1.Jpn J Clin Oncol200535559-5633. Friesen SR. Update on the diagnosis and treatment of rare neuroendocrine tumors. Surg Clin North Am 1987;67:379–393.FriesenSRUpdate on the diagnosis and treatment of rare neuroendocrine tumors.Surg Clin North Am198767379-3934. Long RG, Bryant MG, Mitchell SJ, et al. Clinicopathological study of pancreatic and ganglioneuroblastoma tumours secreting vasoactive intestinal polypeptide (vipomas). Br Med J (Clin Res Ed) 1981;282:1767–1771.LongRG]]BryantMG]]MitchellSJ&etal;Clinicopathological study of pancreatic and ganglioneuroblastoma tumours secreting vasoactive intestinal polypeptide (vipomas).Br Med J (Clin Res Ed)19812821767-17715. Perry RR, Vinik AI. Clinical review 72: diagnosis and management of functioning islet cell tumors. J Clin Endocrinol Metab 1995;80:2273–2278.PerryRR]]VinikAIClinical review 72: diagnosis and management of functioning islet cell tumors.J Clin Endocrinol Metab1995802273-22786. Bloom SR, Yiangou Y, Polak JM. Vasoactive intestinal peptide secreting tumors. Pathophysiological and clinical correlations. Ann N Y Acad Sci 1988;527:518–527.BloomSR]]YiangouY]]PolakJMVasoactive intestinal peptide secreting tumors. Pathophysiological and clinical correlations.Ann N Y Acad Sci1988527518-5277. Jensen RT, Norton JA. Endocrine Tumors of the Pancreas, in Feldman M, Scharschmidt BF, Sleisenger MH (eds): Gastrointestinal and Liver Disease. Philadelphia, PA, WB Saunders, 1998, ed 6, pp 871, 988.8. Kirkwood KS, Debas HT. Neuroendocrine tumors: common presentations of uncommon diseases. Compr Ther 1995;21:719–725.KirkwoodKS]]DebasHTNeuroendocrine tumors: common presentations of uncommon diseases.Compr Ther199521719-7259. Schillaci O, Corleto VD, Annibale B. Single photon emission computed tomography procedure improves accuracy of somatostatin receptor scintigraphy in gastro-entero pancreatic tumours. Ital J Gastroenterol Hepatol 1999;31(suppl 2):S186–S189.SchillaciO]]CorletoVD]]AnnibaleBSingle photon emission computed tomography procedure improves accuracy of somatostatin receptor scintigraphy in gastro-entero pancreatic tumours.Ital J Gastroenterol Hepatol199931S186-S18910. Rösch T, Lightdale CJ, Botet JF, et al. Localization of pancreatic endocrine tumors by endoscopic ultrasonography. N Engl J Med 1992;326:1721–1726.RöschT]]LightdaleCJ]]BotetJF&etal;Localization of pancreatic endocrine tumors by endoscopic ultrasonography.N Engl J Med19923261721-172611. Joyce DL, Hong K, Fishman EK, et al. Multi-visceral resection of pancreatic VIPoma in a patient with sinistral portal hypertension. World J Surg Oncol 2008;6:80.JoyceDL]]HongK]]FishmanEK&etal;Multi-visceral resection of pancreatic VIPoma in a patient with sinistral portal hypertension.World J Surg Oncol200868012. Smith SL, Branton SA, Avino AJ. Vasoactive intestinal polypeptide secreting islet cell tumors: a 15-year experience and review of the literature. Surgery 1998;124:1050–1055.SmithSL]]BrantonSA]]AvinoAJVasoactive intestinal polypeptide secreting islet cell tumors: a 15-year experience and review of the literature.Surgery19981241050-105513. Soga J, Yakuwa Y. Vipoma/diarrheogenic syndrome: a statistical evaluation of 241 reported cases. J Exp Clin Cancer Res 1998;17:389–400.SogaJ]]YakuwaYVipoma/diarrheogenic syndrome: a statistical evaluation of 241 reported cases.J Exp Clin Cancer Res199817389-400
